Dr. John Zinczewski

Equibles does not estimate personal net worth.

About Dr. John Zinczewski

Dr. John Zinczewski has spoken on 1 investor event across 1 company, most recently for Nektar Therapeutics on April 20, 2026. Nektar Therapeutics is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Nektar Therapeutics includes Howard Robin (CEO), Linda Rubinstein (CFO), Sandra Gardiner (CFO) and 2 others.

Dr. John Zinczewski on recent calls

“I'd like to spend a few minutes talking about the opportunity to help patients with alopecia areata and reviewing the mechanism of Treg biology in this disease setting.”

Other, Analyst and Investor Event with Alopecia Areata Experts · April 20, 2026